跳至主要内容
临床试验/CTRI/2022/12/048302
CTRI/2022/12/048302尚未招募2 期

A randomised comparative clinical trial to evaluate the rasayana effect of Amrit Bhallataka and Ashwagandhadi lehya in akaalaja jara (Premature ageing)

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年12月27日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Change in score of Akaalaj jara lakshana

研究概览

简要总结

60 Patients showing more than 3 sign of  premature ageing will be selected and would be randomly divided  in two groups. In first group Amrit Bhallatak  and in second group, Ashawagandhadi lahya  will be given for 48 days. before and after treatment assessment for premature ageing sign, QOL questioner and laboratory investigation - SOD, Hb, LFT would be done.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 1.having 3 symptoms of premature ageing 2.Patients willing to give written informed consent.

排除标准

  • Patients with any type of psychiatric disorder, Alzheimer’s disease, parkinsonism etc.
  • 2.Patients with any major diseases like carcinoma, heart disease, DM, hyperhypothyrodism, hypertension etc.
  •  Patients giving present history of addiction to drug, tobacco or alcohol.
  •  Pitta prakriti person will be excluded on the basis of CCRAS short prakriti performa  Pregnant and lactating females.

结局指标

主要结局

Change in score of Akaalaj jara lakshana

时间窗: 7 weeks

次要结局

  • change in WHO-Quality of Life Bref(Oxidative stress- SOD level)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验